True North Advisors, LLC Medtronic PLC Transaction History

True North Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $116,154 - $132,596	-1,514 Reduced 27.38%	4,015 $323,000
Q3 2022 Nov 10, 2022	SELL	$80.75 - $95.31 $93,993 - $110,940	-1,164 Reduced 17.39%	5,529 $446,000
Q2 2022 Jul 28, 2022	BUY	$87.4 - $113.09 $54,450 - $70,455	623 Added 10.26%	6,693 $600,000
Q1 2022 May 12, 2022	BUY	$100.58 - $112.38 $48,278 - $53,942	480 Added 8.59%	6,070 $673,000
Q4 2021 Feb 11, 2022	SELL	$99.53 - $127.75 $14,431 - $18,523	-145 Reduced 2.53%	5,590 $578,000
Q3 2021 Jun 07, 2022	BUY	$122.75 - $135.17 $21,849 - $24,060	178 Added 3.2%	5,735 $718,000
Q2 2021 Jun 07, 2022	SELL	$118.19 - $131.5 $7,800 - $8,679	-66 Reduced 1.17%	5,557 $689,000
Q4 2020 May 20, 2022	SELL	$100.57 - $117.14 $51,692 - $60,209	-514 Reduced 8.38%	5,623 $658,000
Q3 2020 May 20, 2022	BUY	$90.13 - $108.78 $48,039 - $57,979	533 Added 9.51%	6,137 $637,000
Q2 2020 May 20, 2022	BUY	$84.11 - $103.33 $471,352 - $579,061	5,604 New	5,604 $513,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True North Advisors, LLC with notifications on news.